West Pharmaceutical Services (WST) Restructuring Costs (2009 - 2013)

West Pharmaceutical Services (WST) has reported Restructuring Costs for 5 consecutive years, with $100000.0 the latest figure, recorded in Q3 2013.

• Quarterly Restructuring Costs fell 95.45% year-over-year to $100000.0 in Q3 2013, while the trailing twelve-month figure through Dec 2013 was -$500000.0 (down 138.46% YoY) and the FY2013 annual result came in at -$500000.0, down 138.46% from the prior year.
• Restructuring Costs climbed to $100000.0 in Q3 2013 per WST's latest filing, from -$800000.0 in the prior quarter.
• Over the last five years, Restructuring Costs for WST reached as high as $14.7 million in Q4 2010 and fell as low as -$3.6 million in Q3 2009.
• A 5-year average of $1.9 million and a median of $850000.0 in 2010 frame the typical range for Restructuring Costs.
• Annual changes were most pronounced in 2010 — Restructuring Costs jumped 500.0% — and 2013, when it plunged 260.0%.
• Year by year, Restructuring Costs stood at $11.0 million in 2009, then surged by 33.64% to $14.7 million in 2010, then plunged by 81.63% to $2.7 million in 2011, then plunged by 144.44% to -$1.2 million in 2012, then jumped by 108.33% to $100000.0 in 2013.
• According to Business Quant data, Restructuring Costs over the past three periods registered $100000.0, -$800000.0, and $200000.0 for Q3 2013, Q2 2013, and Q1 2013 respectively.